Cellectis Sa Stock Price History
| CLLS Stock | USD 1.26 0.03 2.44% |
Below is the normalized historical share price chart for Cellectis SA extending back to March 25, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cellectis stands at 1.26, as last reported on the 18th of March 2025, with the highest price reaching 1.26 and the lowest price hitting 1.23 during the day.
If you're considering investing in Cellectis Stock, it is important to understand the factors that can impact its price. Cellectis SA secures Sharpe Ratio (or Efficiency) of -0.0399, which signifies that the company had a -0.0399 % return per unit of risk over the last 3 months. Cellectis SA exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellectis' Standard Deviation of 6.06, risk adjusted performance of (0.07), and Mean Deviation of 3.5 to double-check the risk estimate we provide.
At this time, Cellectis' Total Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation To Revenue is likely to gain to 6.55 in 2025, whereas Common Stock Total Equity is likely to drop slightly above 2.4 M in 2025. . At this time, Cellectis' Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 3.61 in 2025, despite the fact that Price To Operating Cash Flows Ratio is likely to grow to (7.08). Cellectis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of February 2007 | 200 Day MA 1.9341 | 50 Day MA 1.5314 | Beta 3.284 |
Cellectis |
Sharpe Ratio = -0.0399
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLLS |
Estimated Market Risk
| 6.31 actual daily | 56 56% of assets are less volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cellectis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellectis by adding Cellectis to a well-diversified portfolio.
Price Book 0.959 | Enterprise Value Ebitda (3.90) | Price Sales 3.7726 | Shares Float 71.5 M | Wall Street Target Price 5.8 |
Cellectis Stock Price History Chart
There are several ways to analyze Cellectis Stock price data. The simplest method is using a basic Cellectis candlestick price chart, which shows Cellectis price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 6, 2025 | 2.13 |
| Lowest Price | March 6, 2025 | 1.22 |
Cellectis March 18, 2025 Stock Price Synopsis
Various analyses of Cellectis' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cellectis Stock. It can be used to describe the percentage change in the price of Cellectis from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cellectis Stock.| Cellectis Price Rate Of Daily Change | 1.02 | |
| Cellectis Price Daily Balance Of Power | 1.00 | |
| Cellectis Price Action Indicator | 0.03 |
Cellectis March 18, 2025 Stock Price Analysis
Cellectis Stock Price History Data
The price series of Cellectis for the period between Wed, Dec 18, 2024 and Tue, Mar 18, 2025 has a statistical range of 0.91 with a coefficient of variation of 13.66. The prices are distributed with arithmetic mean of 1.58. The median price for the last 90 days is 1.56.| Open | High | Low | Close | Volume | ||
03/18/2025 | 1.23 | 1.26 | 1.23 | 1.26 | ||
| 03/17/2025 | 1.22 | 1.23 | 1.19 | 1.23 | 544,931 | |
| 03/14/2025 | 1.40 | 1.40 | 1.14 | 1.24 | 13,931,761 | |
| 03/13/2025 | 1.30 | 1.33 | 1.27 | 1.29 | 141,354 | |
| 03/12/2025 | 1.28 | 1.31 | 1.22 | 1.30 | 121,467 | |
| 03/11/2025 | 1.28 | 1.32 | 1.22 | 1.25 | 137,701 | |
| 03/10/2025 | 1.26 | 1.29 | 1.20 | 1.22 | 152,519 | |
| 03/07/2025 | 1.28 | 1.31 | 1.25 | 1.25 | 48,755 | |
| 03/06/2025 | 1.25 | 1.27 | 1.22 | 1.22 | 42,372 | |
| 03/05/2025 | 1.31 | 1.31 | 1.28 | 1.28 | 95,263 | |
| 03/04/2025 | 1.29 | 1.35 | 1.25 | 1.26 | 76,611 | |
| 03/03/2025 | 1.36 | 1.37 | 1.27 | 1.29 | 81,898 | |
| 02/28/2025 | 1.34 | 1.34 | 1.24 | 1.29 | 149,071 | |
| 02/27/2025 | 1.40 | 1.40 | 1.32 | 1.33 | 220,782 | |
| 02/26/2025 | 1.46 | 1.48 | 1.39 | 1.40 | 59,824 | |
| 02/25/2025 | 1.46 | 1.52 | 1.33 | 1.39 | 206,721 | |
| 02/24/2025 | 1.52 | 1.55 | 1.47 | 1.50 | 140,728 | |
| 02/21/2025 | 1.56 | 1.60 | 1.52 | 1.53 | 76,715 | |
| 02/20/2025 | 1.57 | 1.62 | 1.52 | 1.54 | 144,514 | |
| 02/19/2025 | 1.53 | 1.61 | 1.52 | 1.54 | 150,223 | |
| 02/18/2025 | 1.53 | 1.62 | 1.51 | 1.58 | 162,987 | |
| 02/14/2025 | 1.61 | 1.61 | 1.52 | 1.55 | 77,558 | |
| 02/13/2025 | 1.50 | 1.55 | 1.46 | 1.53 | 42,086 | |
| 02/12/2025 | 1.50 | 1.54 | 1.46 | 1.48 | 69,518 | |
| 02/11/2025 | 1.54 | 1.55 | 1.50 | 1.51 | 48,487 | |
| 02/10/2025 | 1.55 | 1.61 | 1.51 | 1.55 | 73,584 | |
| 02/07/2025 | 1.60 | 1.63 | 1.53 | 1.53 | 38,216 | |
| 02/06/2025 | 1.60 | 1.69 | 1.58 | 1.59 | 113,277 | |
| 02/05/2025 | 1.66 | 1.70 | 1.56 | 1.60 | 206,795 | |
| 02/04/2025 | 1.58 | 1.65 | 1.58 | 1.63 | 46,933 | |
| 02/03/2025 | 1.54 | 1.61 | 1.51 | 1.56 | 250,887 | |
| 01/31/2025 | 1.59 | 1.65 | 1.58 | 1.61 | 65,036 | |
| 01/30/2025 | 1.53 | 1.59 | 1.51 | 1.58 | 48,578 | |
| 01/29/2025 | 1.56 | 1.56 | 1.45 | 1.52 | 104,451 | |
| 01/28/2025 | 1.53 | 1.65 | 1.51 | 1.54 | 132,547 | |
| 01/27/2025 | 1.65 | 1.67 | 1.52 | 1.54 | 101,383 | |
| 01/24/2025 | 1.59 | 1.72 | 1.53 | 1.67 | 331,282 | |
| 01/23/2025 | 1.54 | 1.65 | 1.52 | 1.56 | 265,578 | |
| 01/22/2025 | 1.52 | 1.56 | 1.50 | 1.53 | 225,050 | |
| 01/21/2025 | 1.57 | 1.59 | 1.46 | 1.51 | 255,781 | |
| 01/17/2025 | 1.51 | 1.54 | 1.46 | 1.48 | 213,838 | |
| 01/16/2025 | 1.64 | 1.64 | 1.51 | 1.51 | 206,574 | |
| 01/15/2025 | 1.72 | 1.77 | 1.60 | 1.64 | 236,513 | |
| 01/14/2025 | 1.74 | 1.80 | 1.66 | 1.68 | 161,208 | |
| 01/13/2025 | 1.83 | 1.89 | 1.65 | 1.68 | 263,417 | |
| 01/10/2025 | 1.93 | 1.93 | 1.82 | 1.85 | 125,461 | |
| 01/08/2025 | 2.03 | 2.03 | 1.88 | 1.93 | 210,196 | |
| 01/07/2025 | 2.19 | 2.22 | 2.09 | 2.10 | 399,567 | |
| 01/06/2025 | 1.79 | 2.23 | 1.76 | 2.13 | 826,154 | |
| 01/03/2025 | 1.80 | 1.80 | 1.66 | 1.68 | 325,995 | |
| 01/02/2025 | 1.78 | 1.84 | 1.77 | 1.81 | 100,542 | |
| 12/31/2024 | 1.88 | 1.95 | 1.77 | 1.80 | 384,383 | |
| 12/30/2024 | 1.45 | 1.82 | 1.45 | 1.82 | 797,203 | |
| 12/27/2024 | 1.51 | 1.59 | 1.41 | 1.41 | 127,160 | |
| 12/26/2024 | 1.56 | 1.59 | 1.51 | 1.51 | 94,180 | |
| 12/24/2024 | 1.57 | 1.61 | 1.53 | 1.56 | 7,303 | |
| 12/23/2024 | 1.59 | 1.62 | 1.57 | 1.57 | 20,375 | |
| 12/20/2024 | 1.58 | 1.64 | 1.53 | 1.64 | 87,886 | |
| 12/19/2024 | 1.62 | 1.62 | 1.58 | 1.59 | 73,884 | |
| 12/18/2024 | 1.69 | 1.72 | 1.60 | 1.63 | 41,020 | |
| 12/17/2024 | 1.72 | 1.78 | 1.69 | 1.71 | 63,166 |
About Cellectis Stock history
Cellectis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cellectis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cellectis SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cellectis stock prices may prove useful in developing a viable investing in Cellectis
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65.6 M | 33.4 M | |
| Net Loss | -95.5 M | -100.3 M |
Cellectis Quarterly Net Working Capital |
|
Cellectis Stock Technical Analysis
Cellectis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Cellectis Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cellectis' price direction in advance. Along with the technical and fundamental analysis of Cellectis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cellectis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | 0.191 | |||
| Treynor Ratio | 0.8921 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.